Abstract:Sepsis, the dysregulated immune response of the host to infections, leads to numerous complications, including multiple organ dysfunction with sepsis-associated acute kidney injury (SA-AKI) being a frequent complication associated with increased risk of mortality and the progression toward chronic kidney disease (CKD). Several mechanisms have been widely investigated in understanding the complex pathophysiology of SA-AKI, including hemodynamic alterations, inflammation, oxidative stress, and direct cellular injury driven by pathogens or cell-derived products (pathogen-associated molecular patterns and damage-associated molecular patterns). Despite advancements in the management of septic patients, the prognosis of SA-AKI patients remains significantly poor and is associated with high in-hospital mortality and adverse long-term outcomes. Therefore, recent research has focused on the early identification of specific SA-AKI endotypes and subphenotypes through epigenetic analysis and the use of potential biomarkers, either alone or in combination with clinical data, to improve prognosis. Epigenetic regulation, such as DNA methylation, histone modifications, and noncoding RNA modulation, is crucial in modulating gene expression in response to stress and renal injury in SA-AKI. At the same time, these modifications are dynamic and reversible processes that can alter gene expression in several pathways implicated in the context of SA-AKI, including inflammation, immune response, and tolerance status. In addition, specific epigenetic modifications may exacerbate renal damage by causing persistent inflammation or cellular metabolic reprogramming, leading to progression toward CKD. This review aims to provide a comprehensive understanding of the epigenetic characteristics that define SA-AKI, also exploring targeted therapies that can improve patient outcomes and limit the chronic progression of this syndrome. Article published online: 29 August 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

The role of nitric oxide in sepsis-associated kidney injury

The Disturbance of Calcium Metabolism of Vascular Smooth Muscle in the Late Phase of Septic Shock and the Underlying Mechanism

NO/cGMP Signal Pathway Involved in the Disturbance of Calcium Homeostasis in Vascular Smooth Muscle During the Late Phase of Sepsis

Nitric Oxide Plays a Dual Role in Cardiorenal Syndrome in Vitro Model

Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review

Gene Expression Profiling of Sepsis-Associated Acute Kidney Injury

Renal neuronal nitric oxide synthase protein expression as a marker of renal injury

[Effects of Nitric Oxide Synthases on Kidney in Early Phase of Endotoxic Shock in Macaque].

Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.

Energy and oxygen metabolism disorder during septic acute kidney injury.

Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury

Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Differential Changes of Nitric Oxide Synthesis in Renal Ischemia Reperfusion Injury

Role of OPG/RANKL/RANK/TLR4 signaling pathway in sepsis-associated acute kidney injury

Acute Kidney Injury in Sepsis

Kynurenine Pathway—An Underestimated Factor Modulating Innate Immunity in Sepsis-Induced Acute Kidney Injury?

Nitric oxide in kidney transplantation

The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury

NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation

Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery

Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury